Neuland Laboratories Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| NEULANDLAB.BO | 000078.SZ | ALKEM.NS | IPCALAB.NS | NATCOPHARM.NS | APLLTD.NS | |
|---|---|---|---|---|---|---|
| Market cap | 250.29B | 3.37B | 620.54B | 494.62B | 156.27B | 175.63B |
| P/E (TTM) | 55.8 | — | 28.8 | 37.8 | 12.6 | 20.8 |
| Forward P/E | 40.6 | 4.0 | 23.2 | 27.7 | 16.8 | 18.2 |
| Price/book | 12.3 | 3.9 | 4.5 | 6.1 | 1.5 | 3.0 |
| Dividend yield | 0.17% | — | 0.38% | 0.30% | 0.75% | 1.32% |
| 1-year change | +10.72% | −50.39% | −7.56% | +51.13% | −1.47% | −0.94% |
| Today | −0.54% | 0.00% | −0.51% | −1.14% | +1.00% | −1.46% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All NEULANDLAB.BO news ›Neuland Laboratories Q2 FY27 Profit Falls 47 Per Cent To ₹51.6 Crore; Revenue Declines 12.5 Pc
New Delhi, November 3, 2026: Hyderabad-based pharmaceutical company Neuland Laboratories Limited on Tuesday reported a sharp decline in earnings for the September quarter (Q2 FY27), with net profit falling nearly 47 per cent year-on-year…
Neuland Laboratories: Betting on new growth avenues
The CMS (contract manufacturing solutions) division manufactures APIs and intermediates, but for innovator companies that are in the clinical testing phase or have commercialised the products. As on June 30, 2026, the company had 99…
Neuland Laboratories NEULANDLAB Special Window Physical Shares
Kalkine India Neuland Laboratories (NSE:NEULANDLAB): Why Did It Open a Special Window for Physical Share Transfer and Dematerialisation? Source: Krish Capital Pty Ltd Neuland Laboratories Limited (NSE:NEULANDLAB) filed a newspaper publi
Neuland Laboratories Signals US FDA Inspection Closure For Unit 3 Manufacturing Facility
Market snapshot: Neuland Laboratories has received indications regarding the closure of the US FDA inspection for its Unit 3 manufacturing facility in Sangareddy District, Telangana. The unit was inspected in August 2026, concluding with a…
Neuland Laboratories NEULANDLAB US FDA EIR Unit 3 Closed
Neuland Laboratories (NSE:NEULANDLAB): What Does the US FDA's Closed EIR Mean for Unit 3? Kalkine India Neuland Laboratories (NSE:NEULANDLAB): What Does the US FDA's Closed EIR Mean for Unit 3? Source: Krish Capital Pty Ltd Neuland…
Neuland Laboratories receives EIR for Gaddapotharam facility from US FDA
Neuland Laboratories received an EIR from US FDA for its Gaddapotharam facility, indicating a closed inspection without further action required. Neuland Laboratories receives EIR for Gaddapotharam facility from US FDA The announcement was…
Peptide Synthesis Market Expands as Neuland Laboratories Adds 7,000 Liters of Commercial Peptide Manufacturing Capacity
The global peptide synthesis market is gaining momentum as pharmaceutical manufacturers expand production capabilities to meet rising demand for peptide based therapeutics In September 2026 Neuland Laboratories commissioned the first…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- kalkine.co.in2
- businessupturn.com1
- freepressjournal.in1
- openpr.com1
- sahi.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.